Design, Optimization, and Biological Evaluation of Novel Tapinarof Analogues as AHR Agonists for Topical Psoriasis Treatment
Journal of Medicinal Chemistry · 25.09.2025 · 68 (18) · 19249-19268
DOI: 10.1021/acs.jmedchem.5c01060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.09.2025. Verfasst von Yunpeng Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Scien…. Hauptthemen laut MEDLINE: Psoriasis, Receptors, Aryl Hydrocarbon, Drug Design, Benzofurans. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Huazhong University of Science and Technology, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Psoriasis is a chronic inflammatory disease that affects the quality of life of patients. The aromatic hydrocarbon receptor (AHR) plays a pivotal role in maintaining the skin barrier integrity. In this study, we conducted a comprehensive analysis of the structure–activity relationship of Tapinarof analogues. Among them, B19 showed low cytotoxicity (>40 μM) and potent AHR agonist activity with an EC50 value of 2.01 nM, which was 14-fold stronger than that of Tapinarof (28.93 nM). B19 exhibited the ability to elevate the transcript levels of key AHR downstream pathway target genes, including CYP1A1 and CYP1B1. Upon topical application, B19 significantly ameliorated imiquimod (IMQ)-induced psoriasis-like cutaneous manifestations and repaired the barrier function of skin, concurrently downregulating the expression levels of CD206, CD36, IL-18, and MCP-1. These findings suggested that B19 represents a potential alternative to Tapinarof for the topical psoriasis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Yonghui Zhang
Förderung
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
- Natural Science Foundation of Hubei Province
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Zhao, Y., Li, Y., Li, L., Wang, Y., Guo, Q., Yang, S., Xiong, C., Luo, F., Hu, Z., Sun, W., Gu, L., & Zhang, Y. (2025). Design, Optimization, and Biological Evaluation of Novel Tapinarof Analogues as AHR Agonists for Topical Psoriasis Treatment. Journal of Medicinal Chemistry, 68(18), 19249-19268. https://doi.org/10.1021/acs.jmedchem.5c01060
Vancouver
Zhao Y, Li Y, Li L, Wang Y, Guo Q, Yang S, et al. Design, Optimization, and Biological Evaluation of Novel Tapinarof Analogues as AHR Agonists for Topical Psoriasis Treatment. Journal of Medicinal Chemistry. 2025;68(18):19249-19268. doi:10.1021/acs.jmedchem.5c01060
BibTeX
@article{Zhao2025,
author = {Zhao, Yunpeng and Li, Yongqi and Li, Lanqin and Wang, Yuanyuan and Guo, Qiang and Yang, Shenglan and Xiong, Chaohu and Luo, Fangzhen and Hu, Zhengxi and Sun, Weiguang and Gu, Lianghu and Zhang, Yonghui},
title = {Design, Optimization, and Biological Evaluation of Novel Tapinarof Analogues as AHR Agonists for Topical Psoriasis Treatment},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {18},
pages = {19249--19268},
doi = {10.1021/acs.jmedchem.5c01060}
}
EUVIMED